Rare Diseases  >>  Synacthen Depot (cosyntropin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Synacthen Depot (cosyntropin) / Novartis, Mallinckrodt, Alliance
2012-001682-33: Rescue of Addison’s disease 2

Ongoing
2
30
Europe
Mabthera Infusion, Solu-Medrone, Synacthen Depot, Rituximab, Methylprednisolone, Tetracosactide acetate, Mabthera infusion, Solu-Medrone, Synacthen Depot, Mabthera infusion, Solu-Medrone, Synacthen Depot
Newcastle upon Tyne Hospitals NHS Foundation Trust, Medical Research Council
Autoimmune Addison\'s disease: autoimmune primary adrenal insufficiency
 
 

Download Options